[1]
2015. QSAR Study and Molecular Docking of 23‐Hydroxybetulinic Acid Derivatives as RMGPa and HeLa Cells Inhibitors. Communications in Computational Chemistry. 3, 3 (Mar. 2015), 75–102. DOI:https://doi.org/10.4208/cicc.2015.v3.n3.2.